Aeterna Zentaris Inc. (NASDAQ:AEZS) on Nov. 4 reported financial and operating results as at and for the third quarter ended September 30, 2014. Net loss for the three-month period ended September 30, 2014 was $11.3 million, or $0.20 per basic and diluted share, compared to a net income of $3.8 million, or $0.13 per basic and diluted share, for the same period in 2013. Cash and cash equivalents totaled $42.0 million as at September 30, 2014, as compared to $43.2 million as at December 31, 2013. Aeterna Zentaris Inc. (NASDAQ:AEZS) belongs to Healthcare sector. Its weekly performance is 16.22%. On last trading day company shares ended up $1.29. Aeterna Zentaris Inc. (NASDAQ:AEZS) distance from 50-day simple moving average (SMA50) is 0.73%. Bank of America Corporation (NYSE:BAC) Chief Executive Officer Brian Moynihan will welcome attendees to the Bank of America Merrill Lynch Banking and Financial Services Conference on Wednesday, November 12 at 8 a.m. Eastern Time in New York. Bank of America Corporation (NYSE:BAC) shares increased 0.76% in last trading session and ended the day at $17.34. BAC return on assets is 0.20%. Bank of America Corporation (NYSE:BAC) quarterly performance is 15.06%. Yahoo! Inc. (NASDAQ:YHOO)’s CEO Marissa Mayer, is a controversial figure, and most of the support that she has been able to garner, which is not that big to begin with, has mostly been after the tech company’s latest earnings release. As a CEO you have to be made of a particularly solid substance in order to survive the criticism that she has been subjected to. On 05 November, Yahoo! Inc. (NASDAQ:YHOO) shares increased 0.81% and was closed at $47.46. YHOO EPS growth in last 5 year was 34.20%. Yahoo! Inc. (NASDAQ:YHOO) year to date (YTD) performance is 17.36%. Enanta Pharmaceuticals (NASDAQ:ENTA) CEO Jay R. Luly unloaded 15,000 shares of Enanta Pharmaceuticals stock in a transaction that occurred on Monday, November 3rd. The stock was sold at an average price of $42.52, for a total transaction of $637,800.00. Following the completion of the transaction, the chief executive officer now directly owns 529,338 shares in the company, valued at approximately $22,507,452. Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) ended the last trading day at $42.18. Company weekly volatility is calculated as 4.61% and price to cash ratio as 8.17. Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) showed a weekly performance of -4.70%. Ameris Bancorp (NASDAQ:ABCB) EVP James A. Lahaise sold 11,733 shares of Ameris Bancorp stock in a transaction that occurred on Wednesday, October 29th. The stock was sold at an average price of $24.38, for a total value of $286,050.54. Following the completion of the sale, the executive vice president now directly owns 61,574 shares in the company, valued at approximately $1,501,174. Ameris Bancorp (NASDAQ:ABCB) shares increased 0.45% in last trading session and ended the day at $24.70. ABCB return on assets is 0.80%. Ameris Bancorp (NASDAQ:ABCB) quarterly performance is 14.56%.
Discover Hidden Gems
Don't miss the next big opportunity. Subscribe for timely alerts on potential market movers.
